UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004108
Receipt number R000004942
Scientific Title A randomized controlled study of long term nutritional management by elemental diet after pancreaticoduodenectomy for biliary tract and pancreatic cancer.
Date of disclosure of the study information 2010/08/31
Last modified on 2015/07/21 12:47:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized controlled study of long term nutritional management by elemental diet after pancreaticoduodenectomy for biliary tract and pancreatic cancer.

Acronym

Effect of long term nutritional management by elemental diet after pancreaticoduodenectomy.

Scientific Title

A randomized controlled study of long term nutritional management by elemental diet after pancreaticoduodenectomy for biliary tract and pancreatic cancer.

Scientific Title:Acronym

Effect of long term nutritional management by elemental diet after pancreaticoduodenectomy.

Region

Japan


Condition

Condition

Biliary tract cancer, Pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effect of long term nutritional management by elemental diet for the improvement of nutritional status, morbidity and compliance of chemotherapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Neutral fat, Total cholesterol, ALT, AST, GGTP, Total protein, albumin, pre-albumin, lymphoid count, serum amino acid(Histidine), SF-36, period to return work, oral intake of baseline, 1, 3 and 6 month after operation

CA19-9 level, toxicity of chemotherapy

Key secondary outcomes

Body weight


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients administered elemental diet (ELENTAL) from enteral feeding tube for 3 month postoperatively.

Interventions/Control_2

Patients administered elemental diet (ELENTAL) from enteral feeding tube until beginning of oral intake.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients received pancreaticoduodenectomy for bile duct cancer or pancreatic cancer

Key exclusion criteria

Patients who have distant metastasis

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koichi Taniguchi

Organization

Yokohama city univercity

Division name

Department of Gastroenterological Surgery

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama city, Kanagawa

TEL

045-787-2650

Email

t1006koichi@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Koichi Taniguchi

Organization

Yokohama city univercity

Division name

Department of Gastroenterological Surgery

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama city, Kanagawa

TEL

045-787-2650

Homepage URL


Email

t1006koichi@yahoo.co.jp


Sponsor or person

Institute

Yokohama city univercity

Institute

Department

Personal name



Funding Source

Organization

Ajinomoto Pharmaceuticals Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 08 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2010 Year 08 Month 31 Day

Date of IRB


Anticipated trial start date

2010 Year 08 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 08 Month 26 Day

Last modified on

2015 Year 07 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004942